# TICU Atrial Fibrillation Treatment Algorithm

**Division of Trauma and Surgical Critical Care**  
*Updated May 2024*

---

## 1. Initial Evaluation

- **Confirm atrial fibrillation** on more than one ECG lead  
- Obtain:
  - CBC, BMP, Magnesium, Calcium, Phosphorus  
  - ± Troponin  
  - Chest X-ray (CXR)  
- **Assess volume status and oxygenation**

---

## 2. Ventricular Response?

### A. **No Rapid Ventricular Response (RVR)**

- **No acute intervention required**
- **Resume rate or rhythm controlling home medications** when able

---

### B. **Rapid Ventricular Response Present**

#### Is the patient hemodynamically unstable?

> **Signs of instability:** Hypotension, altered mental status, ischemia, shock

---

### 3. Hemodynamically Unstable → Immediate Intervention

- Perform **synchronized cardioversion**  
  - **Energy:** 100–200 Joules  
  - **Pre-medicate with sedative** if possible  
- Administer **Magnesium 4 g IV**

---

### 4. Hemodynamically Stable → Rate Control Pathway

#### Preferred Agents

- **Diltiazem (avoid if EF < 40% or hypotensive):**
  - 0.25 mg/kg IV push × 1  
  - If inadequate response, repeat **0.35 mg/kg IV push × 1**  
  - If still no response, start continuous infusion **5–15 mg/hr**

- **Metoprolol (especially if concern for hypotension or persistent hypotension post diltiazem):**
  - 5–10 mg IV every 5 minutes × up to 3 doses

- **Magnesium sulfate 4 g IV** (can be used as adjunctive therapy; especially helpful in COPD/asthma)

---

### 5. Alternative or Escalation Options

If rate remains uncontrolled or rhythm persists:

- **Amiodarone:**
  - 150 mg IV bolus  
  - Then start infusion:
    - 1 mg/min × 6 hrs  
    - Then 0.5 mg/min × 18 hrs  
  - May **repeat 150 mg boluses** or **increase rate back to 1 mg/min** if AF with RVR persists

- **Digoxin:**  
  - Initial dose: 0.25–0.5 mg IV  
  - May repeat 0.25 mg every 6 hrs  
  - **Maximum:** 1.5 mg over 24 hours  
  - Use if **first- and second-line agents** are ineffective or contraindicated

---

## 6. Additional Considerations

- **Identify and address reversible causes:**
  - Fluid overload  
  - Infection/sepsis  
  - Post-operative status  
  - Withdrawal, endocrine, or metabolic causes

- **Reassess rhythm and rate control efforts after 24 hours**
- **Titrate HR to <110 bpm** if hemodynamics allow
- **Anticoagulation** discussion and documentation required if:
  - **New-onset AF** persists for **>48 hours**
- **Cardiology consult** if RVR persists despite escalation

---

## 7. Authors

- **Jill Streams, MD, FACS**  
- **Leanne Atchison, PharmD**  
- **Diana Williams, AGACNP-BC**
